CCL22 and prostate carcinoma: These results showed that CCR2 and CCR4 expressed by the prostate cancer cells were sufficient to cause migration when treated with CCL2, CCL17, and CCL22, or CM collected from U937 cells and M2-type macrophages U937-M cells.